ArticleClinical and translational science2021

Comprehensive in vitro pro-arrhythmic assays demonstrate that omecamtiv mecarbil has low pro-arrhythmic risk.

Yusheng Qu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.